UNQUOTE

Truffle Capital et al. invest €4.8m in Pharnext

  • Greg Gille
  • LinkedIn  
  • Google plus  

French biopharmaceutical company Pharnext has closed a т‚Ќ4.8m series-A round of funding from Truffle Capital, Aurinvest Capital 2, FinanciУЈre Boscari and three individual investors.

The individual investors are French entrepreneurs Charles Beigbeder (founder of Selftrade, Poweo, Audacia and AgroGeneration), Claude Darmon (former president of the CEGELEC group) and Olivier Fulconis (former executive vice president and chief marketing officer at Converteam).

Truffle Capital, a co-founding investor in Pharnext, retains a majority stake in the company, which is now valued at €45m. Pharnext specialises in the developement of treatments based on Pleotherapy for severe neurological diseases.

The unquote" team is currently researching this transaction. In-depth deal information for subscribers will follow shortly.

If you have any information regarding this transaction, please contact Grégoire Gille on +44 20 7484 9824 or gregoire.gille@incisivemedia.com

 

  • LinkedIn  
  • Google plus  

More on France

Latest News